A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus

Update Il y a 4 ans
Reference: NCT00044135

Woman and Man

Extract

The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.


Inclusion criteria

  • Hepatitis B


Links